In MM CD19, CD38, CD138, BCMA, GPRC5D, and Fc receptor-like 5 antigens have been tested (67–69), with early promising responses from BCMA BiTEs treatment in RRMM (66, 69). This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.